Company
iXensor Co. Ltd
Headquarters: Taipei, Taiwan
CEO: Dr. Carson Chen Ph.D.
Market Cap
TW$479.9 Million
TWD as of Jan. 1, 2024
US$15.6 Million
iXensor Co. Ltd Categories
Taiwan Healthcare Medical DevicesTaiwan Healthcare Taiwan Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
iXensor Co., Ltd. develops, produces, and sells hardware and software systems for in-vitro diagnostic medical devices. The company's PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management; and PixoTest POCT Analyzer, COVID-19 Rapid Antigen Test for infectious disease management, as well as PixoHealth Pass Admin app and Web portal. The company was founded in 2012 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
iXensor Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6734 wb_incandescent